CC
KITE

CQS Cayman’s Kite Pharma, Inc. KITE Stock Holding History

CQS Cayman’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-62,200
Closed -$3.47M – 148
2016
Q3 		$3.47M Buy
62,200
+17,200
+38% +$958K 0.29% 62
2016
Q2 		$2.25M Buy
+45,000
New +$2.21M 0.2% 82
2016
Q1 		– Sell
-54,904
Closed -$3.38M – 144
2015
Q4 		$3.38M Buy
+54,904
New +$3.86M 0.23% 76
2015
Q2 		– Sell
-42,100
Closed -$2.43M – 233
2015
Q1 		$2.43M Sell
42,100
-102,900
-71% -$6.9M 0.11% 120
2014
Q4 		$8.36M Buy
+145,000
New +$6.1M 0.56% 44

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

CQS Cayman's KITE Position: Q4 2016 in Review

CQS Cayman sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 62,200 shares — an estimated $3.47M sold.

CQS Cayman first reported a position in KITE in Q4 2014 and held it in 5 quarters. The position peaked at $8.36M in Q4 2014. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

  • CQS Cayman reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
  • CQS Cayman sold 62,200 Kite Pharma, Inc. shares in Q4 2016, an estimated $3.47M.
  • CQS Cayman first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 5 quarters.
  • CQS Cayman's Kite Pharma, Inc. position peaked at $8.36M in Q4 2014.
  • 184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on CQS Cayman's 13F filing for Q4 2016, filed 14 Feb 2017.